-
Mashup Score: 6FDA Update: Agency Approves Abbott TriClip to Treat TR - American College of Cardiology - 22 day(s) ago
The U.S. Food and Drug Administration has approved on April 2 the Abbott TriClip ™, a transcatheter edge-to-edge repair (TEER) system specifically designed for the treatment of tricuspid regurgitation (TR), according to an Abbott press release. The first-of-its-kind device provides a minimally invasive treatment option for patients in need of tricuspid valve repair. Before approving the device, the FDA reviewed results from the TRILUMINATE Pivotal trial, presented at ACC.23/WCC, which found that tricuspid
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Contrast-Sparing Intravascular Ultrasound–Guided Caval Valve Implantation for Severe Symptomatic Tricuspid Regurgitation: - 6 month(s) ago
Abstract Patients with severe tricuspid regurgitation and right ventricular dysfunction have limited therapeutic options due to anatomic complexity, advanced disease at presentation, and comorbidit…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
How familiar are you with #IVUS guidance and bicaval valve implantation in severe #TR and renal dysfunction? Read this insightful article from #JACCCaseReports to expand your knowledge: https://t.co/CzGItXLsUj #vhdTR @tavrkapadia https://t.co/GWVFO591pf
-
-
Mashup Score: 3Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter Treatment - 7 month(s) ago
Abstract Background Although tricuspid transcatheter edge-to-edge repair (TEER) has been suggested to improve outcomes in patients with tricuspid regurgitation (TR), patients remain at substantial …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Dive into groundbreaking research in #JACCINT! Stressed blood volume (SBV) in severe tricuspid regurgitation (TR) reveals the role of SBV in TR and its impact on #TEER outcomes. Could SBV be the key to improving TEER outcomes? 🤔 https://t.co/tAlmLqTSJj #vhdTR #CardioTwitter https://t.co/WOgpY9NQGD
-
-
Mashup Score: 2
Comparing the guidelines is useful and “often leads to some further fine-tuning down the road,” says Robert Bonow.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The American and European guidelines for #cvVHD are mostly concordant, a new comparison study in #JACC shows. The guideline comparison covers #vhdAS, chronic aortic regurgitation, mitral stenosis, chronic #vhdMR, #vhdTR & prosthetic valves. https://t.co/gftTsfWVmE @TCTMD
-
-
Mashup Score: 10Burden of Undiagnosed Valvular Heart Disease in the Elderly in the Community: Heart of New Ulm Valve Study - 9 month(s) ago
∗Minneapolis Heart Institute at Abbott Northwestern Hospital, Allina Health, 920 East 28th Street, Suite 300, Minneapolis, Minnesota 55407, USA. E-mail: E-mail Address: [email protected] Copyright © 2023, American College of Cardiology Foundation. Published by Elsevier Published online April 12,
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Prospective population cohort: #EchoFirst screening of subjects ≥65 years showed 16% prevalence of undiagnosed ≥moderate #cvVHD. #vhdTR > #vhdMR > #vhdAR >> #vhdAS. https://t.co/WANDSph4Dp #JACCIMG #cvImaging #CardioTwitter @MHIValveDoc @rgarberich https://t.co/or1TxJJnli
-
-
Mashup Score: 0Cardiologists detail world's first use of new annuloplasty system for tricuspid regurgitation - 9 month(s) ago
Early data suggest the new transcatheter tricuspid valve repair device could make a big impact on patient care, but additional research is still necessary.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
.@CardioBusiness reports, “A new transcatheter tricuspid annuloplasty system for severe tricuspid regurgitation is safe and associated with significant clinical improvements," according to a first-in-human study: https://t.co/bWcsNDvdcD #vhdTR
-
-
Mashup Score: 1
In older patients with severe or worse tricuspid regurgitation, a tricuspid transcatheter edge-to-edge repair system was safe and improved tricuspid regurgitation grade and quality of life measures for the sickest patients, data show. Philipp Lurz, MD, PhD, professor and deputy head of cardiology, Heart Center Leipzig at University of Leipzig, Germany, presented findings from the bRIGHT
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A tricuspid TEER system improved #vhdTR grade for older patients with severe or worse tricuspid regurgitation, according to research presented at #EuroPCR and published in #JACC. Find out more in @CardiologyToday: https://t.co/temBY8FzNa
-
-
Mashup Score: 2
For adults with severe or greater tricuspid regurgitation, use of a novel transcatheter tricuspid valve replacement system was associated with high procedural success, symptomatic improvement and survival at 2 years, researchers reported.The findings were presented at EuroPCR and simultaneously published in the Journal of the American College of Cardiology.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
For adults with #vhdTR, transcatheter tricuspid valve replacement with the EVOQUE system was associated with high survival & procedural success, according to findings presented at #EuroPCR & published in #JACC. https://t.co/KnI7wWs1o8 @CardiologyToday
-
-
Mashup Score: 1
Clinical Solutions for Everyday Practice
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The ACC thanks the Tricuspid Valve Disease Roundtable participants, planning committee and supporters for their commitment to advancing CV care and exploring challenges clinicians face in the management of patients with #vhdTR. https://t.co/dbuTy9cmKC #TransformCVCare #cvVHD https://t.co/Vno8Sn8shg
-
-
Mashup Score: 6
Procedural Intervention in Valve Disease
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dr. @psorajja addresses gaps in percutaneous management of #vhdTR: “Diagnostic and therapeutic imagine expertise is limited, even in experienced centers.” https://t.co/V7bjEiSmd1 #TransformCVCare #cvVHD https://t.co/fJG3qPeSuq
-
Tricuspid Valve Disease Roundtable Co-Chair, Dr. Vinod H. Thourani, discusses surgical management of #vhdTR: “1.6M in the U.S. have moderate to severe TR prevalence but there are less than 8k surgical procedures annually.” https://t.co/V7bjEiSmd1 #TransformCVCare #cvVHD https://t.co/VfSIxFQggc
-
FDA Update: @US_FDA has approved the Abbott TriClip, a TEER system specifically designed to treat #vhdTR, after reviewing findings from the TRILUMINATE Pivotal trial. Learn more: https://t.co/MVAuQaTPLc